Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440622
Status:
TERMINATED
Last Update Posted:
2013-02-13
First Post:
2007-02-26
Brief Title:
Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 Metastatic Breast Cancer Patients
Sponsor:
Hellenic Oncology Research Group
Organization:
Hellenic Oncology Research Group